QL
RPRX icon

Quarry LP’s Royalty Pharma RPRX Stock Holding History

Quarry LP’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01K Sell
18
-2,444
-99% -$127K ﹤0.01% 1964
2026
Q1 		$118K Buy
+2,462
New +$108K 0.02% 451

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quarry LP's RPRX Position: Q2 2026 in Review

Quarry LP reduced its Royalty Pharma (RPRX) stake by 99% in Q2 2026, selling an estimated $127K and leaving 18 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #1964.

Quarry LP first reported a position in RPRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $118K in Q1 2026. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Quarry LP held 18 shares of Royalty Pharma worth $1.01K as of Q2 2026.
  • Quarry LP sold 2,444 Royalty Pharma shares in Q2 2026, an estimated $127K.
  • Royalty Pharma made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1964 holding.
  • Quarry LP first reported a position in Royalty Pharma in Q1 2026 and has held it in 2 quarters since.
  • Quarry LP's Royalty Pharma position peaked at $118K in Q1 2026.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.